PIII, US7444132044

P3 Health Partners names clinical chief with 110,000-share option for P3 Health Partners stock

Published on 10/16/2026 at 00:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

P3 Health Partners names Michael Millie on October 12, 2026. P3 Health Partners stock is tied to a 110,000-share option with four-year vesting.

Leadership and earnings markers

Michael Millie became chief clinical officer on October 12, 2026, with a 110,000-share option.
Adjusted EBITDA reached USD 54 million in the second quarter after USD 26 million in the first quarter.
P3 Health Partners had a USD 13.6 million market capitalization as of October 15, 2026.
The next reporting date is November 12, 2026.

PIII, US7444132044, Illustration mit AI erstellt.

P3 Health Partners (US7444132044) appointed Michael Millie as chief clinical officer on October 12, 2026, alongside a 110,000-share stock option, according to Business Wire. The appointment places clinical leadership and the related equity award at the center of the latest company update.

Three events mark the year

On May 14, 2026, P3 Health Partners reported USD 26 million of adjusted EBITDA for the first quarter, according to Business Wire. On August 10, 2026, the company reported USD 54 million of adjusted EBITDA for the second quarter, more than double the first-quarter figure, according to Business Wire. On October 12, 2026, it appointed Millie and granted him an option for 110,000 Class A shares.

What does the option mean for P3?

The award has a ten-year term and vests in four equal portions of 25 percent over the first four anniversaries, subject to continued service. It was issued outside the 2021 Incentive Award Plan under Nasdaq Listing Rule 5635(c)(4), giving the appointment a direct equity component.

Next report date is November 12

The next scheduled reporting date is November 12, 2026, for third-quarter results, as listed by JrHisse. The same calendar lists second-quarter revenue of USD 386.38 million and adjusted earnings per share of minus USD 0.63 for the period ended June 30, 2026.

Market value and operating scale

P3 Health Partners had a market capitalization of USD 13.6 million as of October 15, 2026. The company says it works with more than 2,100 affiliated primary care providers across 26 counties in five states, while its value-based care model links clinical coordination with lower care costs.